The world of life and health sciences is witnessing a transformative shift with generative Artificial Intelligence (AI). This technology is not only revolutionizing the way we approach scientific research and laboratory science but is also reshaping the landscape of scientific equipment and instruments.
AI in Biotech: A Revolutionary Leap Forward
The integration of artificial intelligence (AI) in biotech is not just a game-changer; it's the dealer reshuffling the entire deck. We're talking about a seismic shift that's redefining the boundaries of what's possible in healthcare and medicine. AI isn't just streamlining processes; it's rewriting the rule book. From gene editing marvels like CRISPR to the uncharted territories of prime editing, AI is the new alchemist, turning data into gold.
Today we are speaking to Dr Layla Hosseini-Gerami, co-founder of Ignota Labs - an exciting new start-up company aimed at rescuing distressed pharmaceutical assets using Explainable AI .
